Coumarin-Based Fluorescent Inhibitors for Photocontrollable Bioactivation

Area of Science:

• Chemical Biology
• Molecular Medicine
• Drug Delivery Systems

Background:

• The IRE-1/XBP-1 pathway is implicated in various human diseases.
• Coumarin derivatives offer potential as both IRE-1 inhibitors and fluorescent probes.
• Developing integrated fluorescent inhibitor systems requires stable, activatable compounds.

Purpose of the Study:

• To enhance the aqueous stability and photoactivatable drug release of IRE-1 inhibitors.
• To create novel photocaged IRE-1 inhibitors with integrated fluorescence.
• To explore the potential of these compounds in cancer therapy and immune modulation.

Main Methods:

• Structure-activity relationship (SAR) studies of photocaged IRE-1 inhibitor PC-D-F07.
• Synthesis of new derivatives (RF-7, RF-8) incorporating nitrobenzyl photolabile moieties.
• Evaluation of fluorescence response, drug release kinetics, and macrophage repolarization (M2 to M1).

Main Results:

• The electron-withdrawing -NO2 group and tricyclic coumarin core enhance PC-D-F07 stability.
• RF-7 and RF-8 demonstrate increased fluorescence upon photoactivation, enabling controlled drug release.
• RF-7 effectively promotes the conversion of M2-TAMs to M1-type macrophages.

Conclusions:

• Novel photocaged IRE-1 inhibitors (RF-7, RF-8) were successfully synthesized and characterized.
• These compounds enable spatiotemporally controlled drug release via photoactivation.
• RF-7 presents a promising prodrug strategy for precise cancer treatment by modulating the tumor microenvironment.